John C. Cheville

John C. Cheville's AcademicInfluence.com Rankings

John C. Cheville

Philosophy

#5357

World Rank

#8127

Historical Rank

Logic

#2644

World Rank

#3662

Historical Rank

philosophy Degrees

John C. Cheville

Biology

#7149

World Rank

#10022

Historical Rank

Pathology

#89

World Rank

#184

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is John C. Cheville Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John C. Cheville's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Immune Landscape of Cancer (2018) (2766)
Comprehensive molecular characterization of clear cell renal cell carcinoma (2013) (1724)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. (2002) (1062)
Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma (2003) (1026)
Solid renal tumors: an analysis of pathological features related to tumor size. (2003) (1004)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. (2016) (931)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. (2006) (843)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma (2003) (683)
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (2008) (672)
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. (1999) (625)
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. (2004) (613)
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. (2004) (592)
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters (2013) (584)
PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma (2007) (530)
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. (2003) (504)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus (2004) (465)
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) (459)
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. (2000) (373)
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. (2015) (345)
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. (2010) (344)
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. (2003) (328)
Mutations in CHEK2 associated with prostate cancer risk. (2003) (299)
B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival (2006) (288)
Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma (2011) (277)
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness (2005) (253)
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. (2007) (240)
Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality (2014) (237)
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. (2005) (213)
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. (2005) (207)
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. (2000) (200)
Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. (2000) (199)
PTEN Induces Chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression* (2001) (193)
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. (2007) (192)
Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma (2007) (191)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
Sarcomatoid Renal Cell Carcinoma: An Examination of Underlying Histologic Subtype and an Analysis of Associations With Patient Outcome (2004) (185)
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. (2002) (183)
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. (2004) (179)
Tubulocystic Carcinoma of the Kidney: Clinicopathologic Analysis of 31 Cases of a Distinctive Rare Subtype of Renal Cell Carcinoma (2009) (178)
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. (2013) (176)
Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family 1 (2003) (176)
A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease* (2008) (169)
Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? (2005) (167)
Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract (2001) (164)
618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target (2005) (163)
Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. (2002) (160)
Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness (2005) (158)
AGR2, an androgen‐inducible secretory protein overexpressed in prostate cancer (2005) (150)
The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. (1997) (149)
Metanephric Adenoma, Nephrogenic Rests, and Wilms' Tumor: A Histologic and Immunophenotypic Comparison (2001) (146)
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma (2005) (146)
Survival of patients with carcinoma in situ of the urinary bladder (1999) (145)
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer (2015) (140)
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. (2002) (139)
Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. (1998) (138)
Natural history of urothelial dysplasia of the bladder. (1999) (137)
Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer (2009) (136)
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma (2014) (136)
A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. (2003) (132)
Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. (2002) (130)
Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. (2011) (130)
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation. (2015) (129)
Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. (2010) (125)
Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. (2014) (124)
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. (2012) (122)
TFE3 Rearrangements in Adult Renal Cell Carcinoma: Clinical and Pathologic Features With Outcome in a Large Series of Consecutively Treated Patients (2012) (121)
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients (2012) (121)
Multiplex polymerase chain reaction. (1992) (120)
Carcinosarcoma of the prostate. Report of 21 cases (1995) (120)
Cancer volume of lymph node metastasis predicts progression in prostate cancer. (1998) (117)
Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. (2006) (116)
Metastatic prostate carcinoma to bone (2002) (115)
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy (2005) (115)
Frequent microsatellite instability in sporadic tumors of the upper urinary tract. (2002) (113)
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? (2005) (113)
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. (2006) (111)
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? (2005) (110)
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression. (2016) (109)
Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? (1998) (109)
Grading of renal cell carcinoma (1997) (106)
Outcomes following partial nephrectomy by tumor size. (2008) (106)
The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. (2007) (105)
Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival. (2001) (105)
Expression of p27kip1 in prostatic adenocarcinoma. (1998) (104)
Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma (2007) (104)
Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. (2013) (104)
Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. (1998) (102)
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) (102)
Risk factors and outcomes of urethral recurrence following radical cystectomy. (2011) (102)
Cytokeratin expression in seminoma of the human testis. (2000) (102)
Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen (2001) (102)
Flat intraepithelial lesions of the urinary bladder (2000) (101)
Costimulatory B 7-H 1 in renal cell carcinoma patients : Indicator of tumor aggressiveness and potential therapeutic target (2004) (101)
Smooth Muscle Neoplasms of the Urinary Bladder: A Clinicopathologic Comparison of Leiomyoma and Leiomyosarcoma (2002) (100)
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. (2019) (99)
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma (2006) (99)
Renal Carcinoid Tumor: A Clinicopathologic Study of 21 Cases (2007) (98)
Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. (2000) (98)
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) (98)
Leiomyosarcoma of the prostate. Report of 23 cases (1995) (97)
Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors (2013) (96)
The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. (2000) (96)
Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. (2016) (95)
Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. (2018) (95)
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. (2004) (94)
A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis (2013) (94)
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. (2020) (94)
BRAF mutations in metanephric adenoma of the kidney. (2012) (93)
Classification and pathology of testicular germ cell and sex cord-stromal tumors. (1999) (92)
Postatrophic Hyperplasia of the Prostate: A Histologic Mimic of Prostatic Adenocarcinoma (1995) (91)
Primary Vascular Tumors and Tumor-like Lesions of the Kidney: A Clinicopathologic Analysis of 25 Cases (2010) (91)
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. (2005) (91)
Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literature. (2001) (90)
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis. (2013) (90)
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. (2011) (90)
Differences in organ system of distant metastasis by renal cell carcinoma subtype. (2008) (89)
Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. (2012) (89)
Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. (2014) (89)
Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. (2003) (88)
The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. (2003) (88)
Paraganglioma of the urinary bladder (2000) (87)
Tumor B 7-H 1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up (2006) (87)
A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. (2005) (87)
Perineural Invasion and MIB-1 Positivity in Addition to Gleason Score Are Significant Preoperative Predictors of Progression After Radical Retropubic Prostatectomy for Prostate Cancer (2002) (87)
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. (2008) (86)
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. (2013) (86)
Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. (2012) (85)
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. (2017) (85)
Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder (2007) (82)
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. (2008) (81)
Hemangioma of the urinary bladder (1999) (80)
Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. (2007) (79)
Ki‐67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other (2007) (79)
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma (2019) (78)
Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer (2007) (77)
Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review (2003) (77)
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. (2018) (76)
Diagnosis of prostate cancer in needle biopsies after radiation therapy. (1999) (75)
Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. (2017) (75)
Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection (2016) (75)
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma (2006) (73)
Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags. (2002) (72)
Mononuclear cell infiltration in clear‐cell renal cell carcinoma independently predicts patient survival (2006) (72)
Neurofibroma of the urinary bladder (1999) (72)
A novel prognostic model for patients with sarcomatoid renal cell carcinoma (2015) (72)
Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome (2014) (68)
Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors. (2007) (68)
Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. (2003) (67)
The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status. (2010) (66)
Atypical nephrogenic metaplasia of the urinary tract (2000) (66)
Serous Borderline Tumor of the Paratestis: A Report of Seven Cases (2001) (66)
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. (2017) (65)
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. (2020) (65)
Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass. (2008) (65)
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy (2003) (64)
Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. (2015) (64)
Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer. (2002) (63)
Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. (2007) (63)
Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes (2016) (63)
Identification of Prognostic Biomarkers for Prostate Cancer (2008) (63)
Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. (2014) (62)
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. (2017) (62)
Mate Pair Sequencing of Whole-Genome-Amplified DNA Following Laser Capture Microdissection of Prostate Cancer (2012) (62)
Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set (2015) (61)
The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. (2013) (61)
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics (2016) (61)
Adenomatoid Tumor of the Adrenal Gland: A Clinicopathologic Study of Five Cases and Review of the Literature (2003) (61)
Transitional cell carcinoma of the prostate (1998) (61)
Probasin Promoter (ARR2PB)-Driven, Prostate-Specific Expression of the Human Sodium Iodide Symporter (h-NIS) for Targeted Radioiodine Therapy of Prostate Cancer (2003) (60)
pT2 classification for renal cell carcinoma. Can its accuracy be improved? (2005) (59)
Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis (2012) (59)
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management (2017) (59)
Chromophobe Renal Cell Carcinoma: The Impact of Tumor Grade on Outcome (2012) (58)
Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion (2007) (58)
Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus (2015) (57)
Eligibility for neoadjuvant/adjuvant cisplatin‐based chemotherapy among radical cystectomy patients (2014) (57)
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. (2003) (57)
Metastatic potential of a renal mass according to original tumour size at presentation (2012) (57)
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. (2017) (57)
Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes. (2019) (56)
Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. (2019) (56)
Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. (2003) (56)
B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. (2005) (56)
p53 Protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy (1999) (56)
Urothelial papilloma of the bladder (1999) (56)
High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas. (2002) (55)
Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. (2013) (55)
Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma (2019) (54)
Extranodal Extension in Lymph Node–Positive Prostate Cancer (2000) (54)
Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. (2005) (54)
Lineage relationship of Gleason patterns in Gleason score 7 prostate cancer. (2013) (53)
Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. (2018) (53)
Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance. (2017) (52)
Squamous papilloma of the urinary tract is unrelated to condyloma acuminata (2000) (52)
The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer? (2013) (52)
Perivascular Epithelioid Cell Tumor (PEComa) of the Urinary Bladder: Report of 3 Cases and Review of the Literature (2009) (51)
Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. (2005) (51)
Clinical and pathological features associated with the testicular tumor of the adrenogenital syndrome. (2007) (50)
Dedifferentiation in the metastatic progression of prostate carcinoma (1999) (50)
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death (2015) (50)
Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. (2011) (50)
Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma. (2003) (50)
Novel Molecular Targets of Azadirachta indica Associated with Inhibition of Tumor Growth in Prostate Cancer (2011) (49)
The impact of perioperative blood transfusion on survival after nephrectomy for non‐metastatic renal cell carcinoma (RCC) (2014) (48)
Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. (2006) (47)
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long‐term follow‐up (2013) (45)
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. (2017) (45)
Incidence of Succinate Dehydrogenase and Fumarate Hydratase-Deficient Renal Cell Carcinoma Based on Immunohistochemical Screening with SDHA/SDHB and FH/2SC. (2019) (45)
Non-invasive urothelial tumours (2004) (44)
Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. (2003) (44)
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management (2019) (44)
Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi‐Institutional Analysis (2017) (43)
Upper Tract Urothelial Carcinoma: A Clinicopathologic Study Including Microsatellite Instability Analysis (2002) (43)
CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy. (2014) (42)
Outside case review of surgical pathology for referred patients: the impact on patient care. (2013) (42)
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma. (2015) (41)
Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. (2003) (41)
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. (2016) (40)
Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. (1999) (40)
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. (2009) (40)
Synovial Sarcoma of the Kidney: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 16 Cases (2014) (39)
Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. (2006) (39)
UICC drops the ball in the 8th edition TNM staging of urological cancers (2017) (38)
An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. (2004) (38)
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential (2017) (38)
Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer (2016) (38)
ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma (2014) (38)
Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma (2003) (38)
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis (2017) (37)
Inverted urothelial papilloma (2000) (36)
Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. (2011) (36)
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001 (2006) (35)
PDLIM4, An Actin Binding Protein, Suppresses Prostate Cancer Cell Growth (2009) (35)
Enhanced mRNA FISH with compact quantum dots (2018) (35)
Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol (2009) (35)
Long‐term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder (2015) (35)
Low Frequency of Molecular Changes and Tumor Recurrence in Inverted Papillomas of the Urinary Tract (2007) (35)
Histopathological features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of the renal pelvis. (1995) (35)
An Analysis of the p63/α-Methylacyl Coenzyme A Racemase Immunohistochemical Cocktail Stain in Prostate Needle Biopsy Specimens and Tissue Microarrays (2004) (34)
Inverse Association between Programmed Death Ligand 1 and Genes in the VEGF Pathway in Primary Clear Cell Renal Cell Carcinoma (2013) (34)
Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle‐invasive bladder cancer treated with cisplatin‐based neoadjuvant chemotherapy and radical cystectomy: a single‐centre experience (2019) (34)
Complete Surgical Metastasectomy for Renal Cell Carcinoma in the Post-cytokine Era. (2020) (34)
Extragenital adenomatoid tumor of a mediastinal lymph node. (2003) (33)
Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression. (2015) (33)
Utility of Pathology Imagebase for standardisation of prostate cancer grading (2018) (33)
Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. (2014) (32)
pT1 clear cell renal cell carcinoma (2002) (32)
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. (2014) (31)
Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear‐cell renal cell carcinoma (2018) (30)
Three‐dimensional tumour volume and cancer‐specific survival for patients undergoing nephrectomy to treat pT1 clear‐cell renal cell carcinoma (2012) (30)
MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors. (1999) (30)
Ploidy analysis by flow cytometry and fluorescence in situ hybridization in hydropic placentas and gestational trophoblastic disease. (1995) (30)
The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis. (2013) (30)
Microsatellite instability in adenocarcinoma of the prostate. (1994) (30)
Preclinical Evaluation of the Supercritical Extract of Azadirachta Indica (Neem) Leaves In Vitro and In Vivo on Inhibition of Prostate Cancer Tumor Growth (2014) (29)
Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance (2017) (29)
Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model (2016) (29)
Genomic Organization and Expression (2003) (28)
Utility of Gomori methenamine silver stains in bronchoalveolar lavage specimens. (1994) (28)
Long‐term outcome of multiple ipsilateral renal tumours found at the time of planned nephron‐sparing surgery (2008) (28)
Outcome prediction for patients with renal cell carcinoma. (2015) (28)
Surgical Outcomes in Adults With Benign and Malignant Sacrococcygeal Teratoma: A Single-Institution Experience of 26 Cases (2014) (28)
Tumor-Infiltrating Foxp 3 CD 4 + CD 25 + TCells Predict Poor Survival in Renal Cell Carcinoma (2007) (28)
Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma. (2015) (28)
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma (2017) (28)
Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control. (2015) (28)
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. (2002) (27)
Prognostic value of p53 and MIB‐1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement (2004) (27)
The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. (2015) (27)
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma (2015) (27)
Making anatomic terminology of the prostate and contiguous structures clinically useful: Historical review and suggestions for revision in the 21st Century (2009) (26)
Unclassified renal cell carcinoma: impact on survival following nephrectomy. (2010) (26)
Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a Single Institutional Experience with Clinicopathological and Molecular Characteristics. (2021) (26)
Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma (2008) (26)
The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. (2004) (26)
Prognostic Value of Discs Large Homolog 7 Transcript Levels in Prostate Cancer (2013) (25)
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes (2017) (25)
Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy. (2017) (24)
Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. (2005) (24)
Pathologic T1 clear cell renal cell carcinoma: Insulin‐like growth factor‐I receptor expression and disease‐specific survival (2004) (23)
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate (2019) (23)
Leiomyosarcoma of the urinary bladder: a clinicopathological study of 34 cases (2010) (23)
Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. (2006) (23)
Second primary malignancies associated with renal cell carcinoma histological subtypes. (2006) (22)
Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. (2015) (22)
Prediction of radial distance of extraprostatic extension from pretherapy factors. (2007) (22)
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor (2017) (22)
Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma. (1990) (22)
Formation of the 12q14-q15 Amplicon Precedes the Development of a Well-differentiated Liposarcoma Arising From a nonchondroid Pulmonary Hamartoma (2006) (22)
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy (2016) (21)
Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma. (2008) (20)
Are We Using the Best Tumor Size Cut-points for Renal Cell Carcinoma Staging? (2017) (20)
Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. (2012) (20)
Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma. (2014) (20)
The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. (2016) (20)
Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer (2015) (20)
Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. (2020) (20)
High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma (2015) (20)
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma. (2005) (20)
Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines (2006) (19)
Pathology Imagebase—a reference image database for standardization of pathology (2017) (19)
The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens. (2015) (19)
Factors That Influence the Measurement of Prostate Cancer DNA Ploidy and Proliferation in Paraffin Embedded Tissue Evaluated by Flow Cytometry (2001) (19)
Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy (2014) (19)
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia (2021) (19)
Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. (2021) (19)
Isochromosome 12p and polysomy 12 in primary central nervous system germ cell tumors: frequency and association with clinicopathologic features. (2010) (19)
Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. (2003) (18)
Late recurrence after radical cystectomy: patterns, risk factors and outcomes. (2014) (18)
S100 protein expression distinguishes metanephric adenomas from other renal neoplasms. (2008) (17)
Gender-specific survival following radical cystectomy for pT4 bladder cancer (2014) (17)
Downregulation of IgG Fc binding protein (FcγBP) in prostate cancer (2008) (17)
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma (2015) (16)
Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. (2019) (16)
The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy. (2015) (16)
Cysteine-rich Secretory Protein-3 (2002) (16)
Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors (2016) (16)
Urinary collecting system invasion is associated with poor survival in patients with clear‐cell renal cell carcinoma (2017) (16)
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations. (2021) (15)
Expression of endothelin 2 and localized clear cell renal cell carcinoma. (2012) (15)
Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications. (2012) (15)
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma (2017) (15)
Uptake and excretion of Brucella abortus in tissues of the face fly (Musca autumnalis). (1989) (15)
Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. (2017) (15)
Histopathologic characterization of seminal vesicle invasion in prostate cancer: implications for radiotherapeutic management (2001) (14)
Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis. (1994) (14)
Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in‐situ hybridization (1995) (14)
Coffee consumption and risk of renal cell carcinoma (2017) (14)
Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker (2021) (13)
p53 expression in placentas with hydropic change and hydatidiform moles. (1996) (13)
Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery (2020) (13)
Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate cancer. (2008) (13)
Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis. (2015) (13)
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers (2021) (12)
Long Term Outcomes of Patients with Low Grade Cystic Renal Epithelial Neoplasms. (2019) (12)
Maintaining clinical tissue archives and supporting human research: challenges and solutions. (2011) (12)
Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma (2019) (12)
Benign and Malignant Epididymal Masses Evaluated With Scrotal Sonography (2008) (12)
Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma. (2007) (12)
Defining clear cell papillary renal cell carcinoma in routine clinical practice (2020) (12)
Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy (2014) (12)
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less. (2003) (12)
Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole. (1996) (11)
Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure (2020) (11)
Patient factors associated with 30-day complications after partial nephrectomy: A contemporary update. (2017) (11)
Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume (2013) (11)
Urothelial Carcinoma of the Prostate: An Immunohistochemical Comparison with High Grade Prostatic Adenocarcinoma and Review of the Literature (1998) (10)
Transitional cell carcinoma of the bladder mimicking recurrent paget's disease of the vulva: report of two cases, with one occurring in a myocutaneous flap. (2001) (10)
The Association of Aspirin Use with Survival Following Radical Cystectomy (2018) (10)
Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma. (2013) (10)
Iatrogenic splenectomy during nephrectomy for renal tumors (2013) (10)
Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma. (2017) (10)
Genomic tests to guide prostate cancer management following diagnosis (2017) (10)
Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy. (2006) (10)
Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases (2016) (10)
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosis. (2012) (9)
Comparison of quantitative histomorphometry and DNA ploidy in tissue sections of prostate carcinoma. (2002) (9)
Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study. (2003) (9)
Metachronous renal tumours after surgical management of oncocytoma (2011) (9)
The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer (2021) (9)
Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. (2017) (9)
Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma (2018) (9)
Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion (2021) (9)
Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex–associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome (2021) (8)
Sequential imaging of intraneural sciatic nerve endometriosis provides insight into symptoms of cyclical sciatica (2016) (8)
Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma. (2016) (7)
Morphologic Overlap Between Low Grade Oncocytic Tumor (LOT) & Eosinophilic Variant of Chromophobe Renal Cell Carcinoma. (2021) (7)
The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy (2013) (7)
Postatrophic Hyperplasia of the Prostate (1996) (7)
Focal microsatellite mutations in relatives with prostatic adenocarcinoma. (1996) (7)
Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus? (2012) (7)
Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer (2014) (7)
Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features (2021) (7)
Assessment of Isochromosome 12p & 12p Abnormalities in Germ Cell Tumors Using FISH, SNP-Arrays & NGS/ Mate-Pair Sequencing. (2021) (7)
The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis. (2021) (7)
Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors — a major reason for enhanced chemosensitivity? (2017) (7)
Outcomes of patients with sarcomatoid renal cell carcinoma: The Mayo Clinic experience. (2013) (7)
Primary Female Urethral Carcinoma (2020) (7)
Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal masses. (2020) (7)
Comprehensive characterization of perioperative reoperation following radical cystectomy. (2019) (7)
Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy (2017) (7)
Oncologic surveillance following radical cystectomy: an individualized risk-based approach (2017) (6)
Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy (2014) (6)
Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low‐Risk From Intermediate‐ and High‐Risk Prostate Cancer (2019) (6)
Consistency of a two clinical site sample collection: A proteomics study (2010) (6)
Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma. (2014) (6)
Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients. (2020) (6)
Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer. (2017) (6)
Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. (2006) (6)
An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set (2019) (6)
Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20 (2018) (6)
Intratumoral resolution of driver gene mutation heterogeneity in renal cancer using deep learning. (2022) (6)
Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience (2019) (6)
Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. (2018) (6)
Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent. (2016) (6)
Tumor junction burden and antigen presentation as predictors of survival in mesothelioma treated with immune checkpoint inhibitors. (2021) (6)
Renal Neoplasia with Papillary Architecture Involving the Pelvicalyceal System. (2020) (6)
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. (2019) (6)
Large cell calcifying Sertoli cell tumour: a contemporary multi‐institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry (2021) (6)
Urothelial carcinoma of the bladder with choriocarcinomatous differentiation A report of two cases and review of the literature. (1998) (6)
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. (2020) (6)
A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. (2021) (6)
Frequently rearranged and overexpressed δ-catenin is responsible for low sensitivity of prostate cancer cells to androgen receptor and β-catenin antagonists (2018) (5)
Precocious puberty in a 7-year-old boy: a novel case. (2009) (5)
Atheroemboli-associated polyps of the sigmoid colon. (1993) (5)
Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma. (2012) (5)
1073 RADICAL NEPHRECTOMY FOR BENIGN RENAL MASSES IS ASSOCIATED WITH DIMINISHED OVERALL SURVIVAL COMPARED WITH PARTIAL NEPHRECTOMY (2011) (5)
A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease (2018) (5)
A Clinicopathologic Study of Four Cases and Review of the Literature (2016) (5)
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing (2019) (4)
Molecular Modeling and Functional Analysis of Exome Sequencing–Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma (2017) (4)
Expression of CD3 antigens in renal tubule epithelium and renal oncocytomas. (2005) (4)
Long-term outcomes of incidental prostate cancer at radical cystectomy. (2020) (4)
Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma (2014) (4)
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing (2021) (4)
Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy (2019) (4)
710: High Expression Levels of Survivin Protein are an Independent Predictor of Poor Outcome Among Patients Treated Surgically for Clear Cell Renal Cell Carcinoma (2006) (4)
Re: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. V. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A. Swanson and C. G. Wood. J Urol 2007; 178: 1878-1882. (2008) (4)
Squamous Cell Carcinoma of the Bladder is Not Associated with High-Risk HPV. (2020) (4)
22: Cardiopulmonary Bypass with Circulatory Arrest Versus Veno-Venous Bypass in Patients Undergoing Venous Thrombectomy: Comparison of Mortality and Morbidity (2004) (4)
Myeloid sarcoma of the upper extremity causing compartment syndrome: a case report. (2011) (3)
Abstract 3093: Expression of DLL3 in metastatic melanoma, glioblastoma and high-grade extrapulmonary neuroendocrine carcinomas as potential indications for rovalpituzumab tesirine (Rova-T; SC16LD6.5), a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC) (2017) (3)
Imaging , Diagnosis , Prognosis Identification of a Soluble Form of B 7-H 1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma (2011) (3)
Prostate Dimensions and Volume in 700 Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Prostate Cancer Devices (2007) (3)
Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation (2022) (3)
Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy (2020) (3)
1784: Association of Paraneoplastic Syndromes with Outcome Following Radical Nephrectomy for Clear Cell Renal Cell Carcinoma (2004) (3)
Collecting duct carcinoma: A single-institution retrospective study. (2021) (3)
THE CELL CYCLE INHIBITORS p21WAF1 AND p27KIP1 ARE ASSOCIATED WITH SURVIVAL IN PATIENTS TREATED BY SALVAGE PROSTATECTOMY AFTER IRRIDIATION (1999) (3)
MP35-19 THE IMPACT OF EXCESS FAT MASS ON MORTALITY AFTER RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: BEYOND BODY MASS INDEX (2015) (3)
Letters to the Editor/Errata RE: NEPHRON SPARING SURGERY FOR APPROPRIATELY SELECTED RENAL CELL CARCINOMA BETWEEN 4 AND 7 CM RESULTS IN OUTCOME SIMILAR TO RADICAL NEPHRECTOMY (2004) (3)
Diffuse Pulmonary Meningotheliomatosis: A Rare Lung Disease Presenting with Diffuse Ground-Glass Opacities and Cavitation (2020) (3)
573 THE RELATIONSHIP OF LYMPH NODE DISSECTION WITH RECURRENCE AND SURVIVAL FOR PATIENTS TREATED WITH NEPHRECTOMY FOR HIGH-RISK RENAL CELL CARCINOMA (2012) (3)
Survival for patients with residual tumor at radical cystectomy following chemotherapy: A matched analysis to cystectomy-only patients. (2017) (3)
Intratumoral CD 14 þ Cells and Circulating CD 14 þ HLA-DRlo / neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma (2015) (3)
[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations]. (2014) (3)
Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy. (2022) (3)
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. (2020) (2)
Clinical and surgical management of a congenital Type II split cord malformation presenting with progressive cranial neuropathies: case report. (2017) (2)
Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? (2020) (2)
Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9. (2015) (2)
1801 COMPLICATIONS AND OUTCOMES FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS: RESULTS FROM THE MAYO CLINIC (2012) (2)
A 51-year-old man with rapidly progressive metastatic sarcomatoid renal cell carcinoma: an apparent complete clinical response to second-line therapy with sunitinib and low-dose interferon-alpha. (2011) (2)
Lessons From Histopathologic Examination of Nephrectomy Specimens in Patients with Tuberous Sclerosis Complex: Cysts, Angiomyolipomas & Renal Cell Carcinoma. (2022) (2)
Association of loss of BAP1 expression in cell renal cell carcinomas with PDL1 expression. (2014) (2)
Deepfake histological images for enhancing digital pathology (2022) (2)
Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84. (2014) (2)
Abstract 3092: Urine-derived urinary carcinoma organoids: A novel tool for providing new insights into human and canine bladder cancer treatment (2022) (2)
Prostatic Stromal Hyperplasia with Atypia (2013) (2)
Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci (2017) (2)
Outcomes of patients with high-risk non-muscle invasive bladder cancer (NMIBC) who undergo radical cystectomy after BCG and subsequent salvage intravesical therapy. (2020) (2)
Fumarate Hydratase (FH) c.1431_1433dupAAA (p.Lys477dup) variant is not associated with FH protein deficiency and increased 2SC in two separate patients with renal neoplasia (2021) (2)
A microRNA Transcriptome-wide Association Study of Prostate Cancer Risk (2022) (2)
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. (2019) (2)
CIC-rearranged undifferentiated round cell sarcoma metastatic to the brain treated with surgery and stereotactic radiosurgery: Case report. (2020) (2)
Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib (2016) (2)
Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by 11 C-Choline Positron Emission (2015) (2)
742: Features Predictive of Local Recurrence Following Nephron-Sparing Surgery for Renal Caell Carcinoma (2006) (2)
Les tumeurs rénales: Recommandations de la conférence de consensus de I'International Society of Urologic Pathology (ISUP) 2012 (2014) (2)
MP44-14 PARANEOPLASTIC SYNDROMES ARE ASSOCIATED WITH ADVERSE PROGNOSIS AMONG PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY (2015) (2)
1777: Differences in Site of Distant Metastases by Renal Cell Carcinoma Subtype (2004) (2)
Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9. (2015) (2)
Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer (2022) (1)
LONG TERM OUTCOMES OF PATIENTS WITH CYSTIC CLEAR CELL RENAL CELL CARCINOMA: MP55‐07 (2017) (1)
Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia (2021) (1)
Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) (1)
An update on computational pathology tools for genitourinary pathology practice: A review paper from the Genitourinary Pathology Society (GUPS) (2022) (1)
A Diagnostic Approach to Paratesticular Lesions with Tubulopapillary Architecture: A Series of 16 Serous Borderline Tumors/Low-Grade Serous Carcinoma & 14 Well-Differentiated Papillary Mesothelial Tumors and Mesothelioma. (2022) (1)
MP50-17 LATE RECURRENCE FOLLOWING RADICAL CYSTECTOMY: PATTERNS, RISK FACTORS, AND OUTCOMES (2014) (1)
Association of topoisomerase II expression and cancer-specific death in patients with surgically resected clear cell renal cell carcinoma. (2013) (1)
Immunohistochemical Expression of Renin & GATA3 Help Distinguish Juxtaglomerular Cell Tumors from Renal Glomus Tumors. (2022) (1)
1765: An Outcome Prediction Model for Cancer-Specific Survival Following Metastatic Clear Cell Renal Cell Carcinoma (2004) (1)
The association of anxiety and depression with mortality risk among patients with clear cell renal cell carcinoma undergoing nephrectomy. (2019) (1)
978 PTEN DELETION AND MUTATION IN CLINICALLY INSIGNIFICANT AND SIGNIFICANT PROSTATE CANCER: AN ANALYSIS BY MATE-PAIR NEXT GENERATION AND SANGER SEQUENCING (2013) (1)
Cryoablation of cT1 renal masses in the “healthy” patient: Early outcomes from Mayo Clinic. (2017) (1)
Re: Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology. (2004) (1)
Molecular analysis of inverted tumors of the urinary bladder (2005) (1)
Classification of Adult Renal Tumors and Grading of Renal Cell Carcinoma (2015) (1)
Brachytherapy as Adjunctive Therapy in Subglottic Stenosis (2004) (1)
963: Histologic Coagulative Tumor Necrosis: An Important Prognostic Feature of Renal Cell Cancer (2005) (1)
1127: Association of Preoperative Elevated Erythrocyte Sedimentation Rate and Anemia with Survival Following Radical Nephrectomy for Chromophobe, Papillary, and Clear Cell Renal Cell Carcionoma (2006) (1)
Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning? (2018) (1)
PD04-01 RENAL CELL CARCINOMA WITH ISOLATED LYMPH NODE INVOLVEMENT: NATURAL HISTORY AND PREDICTORS OF ONCOLOGIC OUTCOMES (2016) (1)
MP25-06 COMPLETE METASTASECTOMY FOR RENAL CELL CARCINOMA IN THE CONTEMPORARY ERA (2019) (1)
Cell Carcinoma Patients with Long-term Follow-up Tumor B 7-H 1 Is Associated with Poor Prognosis in Renal (2006) (1)
Validation of an inverse association between programmed death ligand 1 (PDL1) and genes in the vascular endothelial growth factor (VEGF) pathway in primary clear cell renal cell (ccRCC). (2013) (1)
Lymph node dissection is not associated with increased 30-day complications among patients undergoing radical nephrectomy for renal cell carcinoma: A propensity-score based analysis (2017) (1)
746: Mononuclear Cell Infiltration in Clear Cell Renal Cell Carcinoma Independently Predicts Patient Survival (2006) (1)
Urothelial dysplasia: Diagnostic value in clinical practice 20 years since the 1998 who/isup consensus (2020) (1)
396 CANCER-SPECIFIC MORTALITY FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER WITH LYMPH NODE INVOLVEMENT: IMPACT OF DISEASE FEATURES AND ADJUVANT CHEMOTHERAPY (2013) (1)
MP31-07 SIMULTANEOUS VERSUS STAGED PARTIAL NEPHRECTOMIES FOR BILATERAL SYNCHRONOUS SOLID RENAL MASSES (2019) (1)
Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses (2022) (1)
Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9. (2015) (1)
Abstract LB-155: Rapid patient derived xenograft avatars that consider tumor heterogeneity for prediction of cancer immunotherapy responses in metastatic renal cell carcinoma patients (2018) (1)
The impact of surgical resection on circulating tumor-reactive cytotoxic T cells for patients with renal tumors. (2020) (1)
Imaging of the Bulbourethral (Cowper) Gland: Abnormalities and Differential Diagnosis. (2022) (1)
Randomized phase II trial of intravenous ascorbic acid (AA) as an adjunct to pazopanib for metastatic and unresectable clear cell renal cell carcinoma (ccRCC): A study of Academic and Community Cancer Research United (ACCRU) GU1703. (2019) (1)
LONG-TERM FOLLOW-UP OF PATIENTS WITH CARCINOMA IN SITU OF THE URINARY BLADDER (1999) (1)
Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology. (2021) (1)
PD35-07 EVALUATION AND MANAGEMENT OF RENAL FOSSA RECURRENCE FOLLOWING NEPHRECTOMY FOR RENAL CELL CARCINOMA (2015) (1)
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. (2022) (1)
Modeling E‐Cadherin Expression Status to Predict Bladder Cancer Progression: 218 (2018) (1)
1115: The Impact of Lymphadenectomy at the Time of Nephrectomy for Metastatic RCC (2006) (1)
Primary Female Urethral Carcinoma Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas (2020) (1)
Comment on: Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy. Authors' reply (2008) (1)
POD-03.07: High tumor expression of KI-67 is an independent predictor of poor outcome among patients treated surgicaly for clear cell renal cell carcinoma (2007) (1)
Do We Have Sufficient Evidence to Define Prognosis for "Low-grade" Fumarate Hydratase-deficient Renal Cell Carcinoma? (2022) (1)
Images - Penile pain in the setting of end-stage renal disease: An unusual anatomic location for calciphylaxis. (2021) (1)
Chromosomal Junction Detection from Whole Genome Sequencing on Formalin-fixed, Paraffin-embedded Tumors. (2020) (1)
Mass Spectrometry-Based Assessment of Prostate Cancer-Associated Crystalloids Reveals Enrichment for Growth & Differentiation Factor 15 (GDF15). (2023) (0)
MP69-05 EVALUATION OF POST-OPERATIVE COMPLICATIONS AND PROLONGED LENGTH OF STAY FOLLOWING CYTOREDUCTIVE NEPHRECTOMY (2015) (0)
RADICAL NEPHRECTOMY WITH OR WITHOUT LYMPH NODE DISSECTION FOR NON‐METASTATIC RENAL CELL CARCINOMA: A MULTI‐INSTITUTIONAL ANALYSIS: MP55‐16 (2017) (0)
1256: Lower Tumor Expression Levels of the Transforming Growth Factor Beta Receptor Type II Protein are Associated with a Less Aggressive Tumor Phenotype and Improved Survival Among Patients with Clear Cell Renal Cell Carcinoma (2007) (0)
Su1277 Tumor Heterogeneity Assessment of EUS FNA Cytology to Matched Surgical Pathology via Targeted Next Generation Sequencing in a Pancreatic and Ampullary Adenocarcinoma Population (2016) (0)
MP-04.07: CD-4+ CD-25+ regulatory T-cells in the tumor draining lymph nodes of patients with urothelial carcinoma (2007) (0)
Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. (2022) (0)
PD04-04 OPTIMIZING PATIENT SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA (2016) (0)
1121: The Relationship between Renal Angiomyolipoma, Renal Cell Carcinoma and Tuberous Sclerosis (2006) (0)
Loss of BAP1 and PBRM1 expression in non-clear cell renal cell carcinomas compared to clear cell renal cell carcinomas. (2014) (0)
Sa1521 SMAD4 Biomarker Stratification Strategy via Endoscopic Ultrasound Fine Needle Aspiration Using Targeted Next-Generation Sequencing for Patients With Pancreatic and Ampullary Adenocarcinoma (2016) (0)
960: Preoperative Prediction of Pathologic Features and Outcome in Patients with Clinically Confined Solid Renal Tumors (2005) (0)
MP35-18 SARCOPENIA IS INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY FOLLOWING RADICAL NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA (2015) (0)
PD38-06 RISK SCORE PREDICTION MODEL FOR BLADDER CANCER USING COMBINATION OF IMMUNOSCORE AND PATHOLOGICAL STAGING (2016) (0)
A retrospective review of solid epididymal masses evaluated by scrotal sonography with pathologic and clinical correlation (2006) (0)
Prostate Volume in Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Imaging and Treatment Devices for the Prostate (2014) (0)
Re: Stanley Weng, Renzo G. DiNatale, Andrew Silagy, et al. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. Eur Urol 2021;79:468-77. (2021) (0)
733: Cancer-Specific Mortality is Increased by Erythrocyte Transfusion in Patients Undergoing Surgery for Renal Cell Carcinoma (2006) (0)
Testis, Penis, and Paratesticular Region (2002) (0)
MP70-11 RADIOGRAPHIC PREDICTORS OF THE NEED FOR INFERIOR VENA CAVAL RESECTION DURING NEPHRECTOMY FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2015) (0)
MP64-11 EVALUATION OF SURGICAL COMPLICATIONS IN A CONTEMPORARY SERIES OF PARTIAL NEPHRECTOMY PATIENTS (2016) (0)
PD25-10 ESTIMATION OF THE RISK OF MISSING ADVERSE PATHOLOGICAL PROSTATE CANCER FEATURES AFTER SALVAGE RADICAL PROSTATECTOMY IN PATIENTS ELIGIBLE FOR FOCAL SALVAGE THERAPIES (2019) (0)
448: Tumor Vasculature Expression of B7-H3 in Renal Cell Carcinoma (2007) (0)
MP42-14 UPSTAGING OF CHRONIC KIDNEY DISEASE AFTER PARTIAL AND RADICAL NEPHRECTOMY (2021) (0)
957 The impact of non-clear cell histology on outcome for patients with renal cell carcinoma and venous tumor thrombus (2013) (0)
PD11-06 COMPREHENSIVE CHARACTERIZATION OF RETURNS TO THE OPERATING ROOM FOLLOWING RADICAL CYSTECTOMY (2018) (0)
Abstract No. 191 Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with adrenocorticotropic hormone–independent Cushing syndrome and bilateral adrenal masses (2021) (0)
George M. Farrow, MD: A Tribute. (2019) (0)
Chest wall resection for breast cancer: 21st century Mayo clinic experience (2022) (0)
507: Patients with PT1 Renal Cell Carcinoma who Die from Disease after Nephrectomy may have Unrecognized Renal Sinus Fat Invasion (2007) (0)
Association of perioperative venous thromboembolism with long-term oncologic outcomes following radical cystectomy. (2017) (0)
PD51-03 PERCUTANEOUS ABLATION OFFERS COMPARABLE ONCOLOGIC CONTROL COMPARED WITH PARTIAL NEPHRECTOMY FOR cT1 RENAL MASSES (2019) (0)
Juxtaglomerular cell tumor. Authors'reply (2002) (0)
PD52-06 CLINICAL PREDICTORS AND SURVIVAL OUTCOME OF PATIENT RECEIVING SUBOPTIMAL NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER: A SINGLE-CENTER EXPERIENCE (2019) (0)
Understanding the genomic underpinnings of metastatic chromophobe renal cell carcinoma. (2016) (0)
Prognostic impact of peripheral blood counts in patients with non-metastatic clear cell renal cell carcinoma. (2015) (0)
MP61-14 THE IMPACT OF NEOADJUVANT CHEMOTHERAPY ON THE TIMING AND SITE OF RECURRENCE FOLLOWING RADICAL CYSTECTOMY (2016) (0)
361 RISK FACTORS AND OUTCOMES OF URETHRAL RECURRENCE FOLLOWING RADICAL CYSTECTOMY (2011) (0)
Studies Ability of Biomarkers to Predict Systemic Progression en with High-Risk Prostate Cancer Treated R gically Is Dependent on ERG Status (2010) (0)
519 SPARC (SURVIVAL PREDICTION AFTER RADICAL CYSTECTOMY): A MULTIFACTORIAL OUTCOME PREDICTION MODEL FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER (2013) (0)
PD29-06 ONCOLOGIC SURVEILLANCE FOLLOWING SURGICAL RESECTION FOR RENAL CELL CARCINOMA: A NOVEL RISK-BASED APPROACH (2015) (0)
Bladder , Penis and Urethral Cancer , and Basic Principles of Oncology Re : Outcome of Patients with Micropapillary Urothelial Carcinoma following Radical Cystectomy : ERBB 2 ( HER 2 ) Amplification Identifies Patients with Poor Outcome (2015) (0)
MP03-05 RADIOGRAPHIC SIZE OF RETROPERITONEAL LYMPH NODES PREDICTS PATHOLOGIC NODAL INVOLVEMENT FOR PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: DEVELOPMENT OF A RISK PREDICTION MODEL (2016) (0)
MP48-14 RADICAL VERSUS PARTIAL NEPHRECTOMY FOR CT1 RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS (2018) (0)
2022-RA-1499-ESGO Differential response of in-vitro mismatch repair-deficient hypermethylated endometrioid endometrial cancer models to DNA-hypomethylating agents (2022) (0)
MP09-11 CONTEMPORARY INCIDENCE AND PREDICTORS OF DOWNGRADING FOR GLEASON 8 PROSTATE CANCER: IMPLICATIONS FOR RISK CLASSIFICATION AND TREATMENT (2019) (0)
Abstract 2509: Similar variant histology and immune cell infiltration in canine and human muscle-invasive bladder cancer (2023) (0)
PD27-03 ONCOLOGIC SURVEILLANCE FOLLOWING RADICAL CYSTECTOMY: AN INDIVIDUALIZED RISK-BASED APPROACH. (2016) (0)
EXTH-20. IDENTIFICATION OF EX VIVO THERAPEUTIC VULNERABILITIES IN DIFFUSE GLIOMAS USING A FUNCTIONAL GENOMICS APPROACH (2022) (0)
PD16-03 THE IMPACT OF PERIOPERATIVE BLOOD TRANSFUSION ON SURVIVAL FOLLOWING NEPHRECTOMY FOR NON METASTATIC RENAL CELL CARCINOMA (2014) (0)
PD16-12 PROGNOSTIC EVALUATION OF PERINEPHRIC FAT, RENAL SINUS FAT, AND RENAL VEIN INVASION FOR PATIENTS WITH PATHOLOGIC STAGE T3A RENAL CELL CARCINOMA (2018) (0)
The impact of rhabdoid differentiation on prognosis in patients with grade 4 renal cell carcinoma. (2015) (0)
MP66-12 BIM EXPRESSION IN PERITUMORAL LYMPHOCYTES IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA (2018) (0)
1294 ELIGIBILITY FOR NEOADJUVANT/ADJUVANT CISPLATIN-BASED CHEMOTHERAPY AMONG RADICAL CYSTECTOMY PATIENTS (2013) (0)
MP64-01 RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH SURVIVAL OUTCOMES AMONG PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS (2016) (0)
Whole blood androgen receptor (AR) variant (ARV12, ARV14) expression and overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC). (2017) (0)
PD56-03 CONTEMPORARY PERIOPERATIVE COMPLICATIONS OF SURGERY FOR RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA THROMBECTOMY (2022) (0)
Whole blood mRNA expression for prognosis of metastatic clear cell renal carcinoma (mCCRCC). (2017) (0)
Abstract 3008: Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer (2012) (0)
PD11-01 LONG TERM ONCOLOGIC OUTCOMES OF SURGICALLY TREATED RENAL ONCOCYTOMA (2020) (0)
CRYOABLATION OF CT1 RENAL MASSES IN “HEALTHIER” PATIENTS: EARLY OUTCOMES FROM MAYO CLINIC: MP100‐06 (2017) (0)
Abstract 3048: Surfaceome profiling identifies the immune checkpoint molecule B7-H3 as a key player of immune-evasion in rhabdomyosarcoma (2021) (0)
still believe that the absence of staining in oncocytoma and chromo- phobe RCC (reiterated in their Table) may prove useful for patholo- gists reviewing needle biopsy specimens of renal masses. (2008) (0)
Aberrant expression of costimulatory B7-H1 in clear cell renal cell carcinoma (2005) (0)
Abstract 4056: Hypoxia as a tool for identifying prostate cancer-associated antigens. (2013) (0)
MP66-03 DISTRIBUTION OF M0 RENAL CELL CARCINOMA METASTASES STRATIFIED BY PATHOLOGIC NODAL STATUS (2018) (0)
MP28-12 THE IMPACT OF METASTASIS HISTOPATHOLOGY ON SURVIVAL FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (2023) (0)
MP58-09 THE PATHOLOGIC FEATURES IN RADICAL CYSTECTOMY SPECIMENS OF PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR BLADDER CANCER: IS TUMOR REGRESSION IMPORTANT? (2015) (0)
Survival outcomes of metastasis-directed therapy for solitary sites of metastatic clear cell renal cell carcinoma. (2023) (0)
POS-02.88: Gamma-delta T lymphocytes are of no prognostic value in clear cell renal cell carcinoma (2007) (0)
1779: Cancer-Specific Survival in Patients with PT2 Renal Cell Carcinoma: is the Current Tumor Classification Accurate? (2004) (0)
Cytogenetics of Spermatocytic Tumors with a Discussion of Gain of Chromosome 12p in "Anaplastic Variants". (2022) (0)
961: Scoring Algorithm to Predict Cancer-Specific Survival for Patients with Metastatic Renal Cell Carcinoma (2005) (0)
Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities (2023) (0)
MP47-03 MAYO CLINIC VALIDATION OF THE AMERICAN UROLOGIC ASSOCIATION RISK GROUPS FOR LOCALIZED RENAL CANCER (2022) (0)
1652: Independent Validation of the 2003 AJCC Tumor Staging System Using a Large Single-Institution Cohort of Patients Treated with Radical Nephrectomy (2004) (0)
PD08-04 VIRTUAL RENAL MASS BIOPSY: PREDICTING RENAL TUMOR HISTOLOGY ON ABDOMINAL CT IMAGES USING MACHINE LEARNING (2023) (0)
1110: Cystic Clear Cell Renal Cell Carcinoma is Cured by Surgical Resection (2006) (0)
MP73-13 MULTI-INSTITUTIONAL OUTCOMES OF PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WHO UNDERGO RADICAL CYSTECTOMY AFTER BCG AND SUBSEQUENT SALVAGE INTRAVESICAL THERAPY (2020) (0)
PD33-03 IS ANGIOTENSIN SYSTEM INHIBITOR USE ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH LOCALIZED CLEAR CELL RCC? (2022) (0)
MP50-15 CHROMOPHOBE RENAL CELL CARCINOMA – EVIDENCE FOR A NEW GRADING SYSTEM (2020) (0)
Evaluation of post-operative complications and prolonged length of stay following cytoreductive nephrectomy. (2015) (0)
ONCOLOGIC OUTCOMES FOR PATIENTS WITH RESIDUAL CANCER AT CYSTECTOMY FOLLOWING PREOPERATIVE CHEMOTHERAPY: A PATHOLOGIC STAGE‐MATCHED COMPARATIVE ANALYSIS: MP34‐03 (2017) (0)
PD46-12 LONG TERM OUTCOMES OF PATIENTS WITH LOW GRADE CYSTIC EPITHELIAL RENAL NEOPLASMS (2019) (0)
Sa1355 Molecular Cytology Genotyping of Primary and Metastatic Gastrointestinal Stromal Tumors Using Targeted Next Generation Sequencing to Guide Therapeutic Decision Making (2016) (0)
Cardiopulmonary bypass with circulatory arrest versus veno-venous bypass in patients undergoing venous thrombectomy Comparison of mortality and morbidity (2004) (0)
Ability of Biomarkers to Predict Systemic Progression en with High-Risk Prostate Cancer Treated (2010) (0)
Sa1455 KRAS Mutant Subtype Assessment of Pancreatic and Ampullary Adenocarcinoma by EUS FNA Molecular Cytology Targeted Next Generation Sequencing (2016) (0)
Letters to the Editor/Errata Re: Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis (2013) (0)
Integrin α5β1 as a Novel Therapeutic Target in Renal Cancer (2009) (0)
965: Erythrocyte Sedimentation Rate: An Independent Prognostic Feature of Clear Cell Renal Cell Cancer (2005) (0)
Clinical Reasoning: An unusual cause of indeterminate spells (2016) (0)
EAU and NCCN surveillance guidelines for bladder cancer: Do they effectively capture recurrences following cystectomy? (2014) (0)
PD56-11 ANALYSIS OF METHYLATED DNA MARKERS FOR PREDICTION OF CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY (2018) (0)
Urological Oncology: Adrenal, Renal, Ureteral and Retroperitoneal Tumors (2014) (0)
Tu1479 The Potential of an Endoscopic Ultrasound Fine Needle Aspiration Biomarker Stratification Strategy Using Targeted Next-Generation Sequencing for Patients With Pancreatic and Ampullary Adenocarcinoma (2016) (0)
1903 PATHOLOGIC SUBSTAGING IMPROVES PROGNOSTIC STRATIFICATION IN PATIENTS WITH PT3 BUT NOT PT2 UROTHELIAL CARCINOMA FOLLOWING RADICAL CYSTECTOMY (2012) (0)
MP78-02 URINARY COLLECTING SYSTEM INVASION IS ASSOCIATED WITH POOR SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA PATIENTS (2016) (0)
1614 COMPARATIVE PERFORMANCE OF COMORBIDITY INDICES FOR ESTIMATING PERIOPERATIVE AND 5-YEAR ALL-CAUSE MORTALITY FOLLOWING RADICAL CYSTECTOMY (2013) (0)
1108: Surgical Management, Complications, and Outcome of Vascular Bypass for Renal Cell Carcinoma with Venous Tumor Thrombus (2007) (0)
Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors (2016) (0)
718: Influence of Activated T Cells on Bladder Cancer Progression (2004) (0)
Clinical/ Immunopathological Presentations and Antigen-specific CD8+ T Cell Responses in Paraneoplastic Autoimmune KLHL11 Encephalitis (1185) (2020) (0)
Juxtaglomerular cell tumor (multiple letters) (2002) (0)
MP54-12 DIABETES MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OF CANCER-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY (2014) (0)
Association and prognostic impact of peripheral blood counts with tumor programmed death ligand one expression. (2015) (0)
Association of prior pelvic radiation with long-term oncologic outcomes following radical cystectomy. (2017) (0)
MP60-05 WHEN CAN ONCOLOGIC SURVEILLANCE FOLLOWING RADICAL CYSTECTOMY BE SAFELY DISCONTINUED? (2014) (0)
MP70-15 INCREASING COMPLEXITY OF TUMOR THROMBI IN RENAL CELL CARCINOMA OVER 40 YEARS OF EXPERIENCE (2015) (0)
MP03-11 RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL AMONG PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS (2016) (0)
OP3-07 HOW EFFECTIVELY DO EAU AND NCCN SURVEILLANCE GUIDELINES CAPTURE RECURRENCES FOLLOWING RADICAL CYSTECTOMY? (2014) (0)
MP64-19 FACTORS PREDICTING BLOOD LOSS AND POSITIVE MARGINS AT TIME OF PARTIAL NEPHRECTOMY: ANALYSIS OF A CONTEMPORARY COHORT (2016) (0)
CD274 (PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract. (2021) (0)
75 Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients (2013) (0)
1897 OUTCOMES AND CLINICOPATHOLOGIC PREDICTORS ASSOCIATED WITH LATE RECURRENCE AFTER RADICAL CYSTECTOMY (2012) (0)
Penile Squamous Cell Carcinoma Exclusive to the Shaft, with a Proposal for a Novel Staging System. (2022) (0)
1295: Comparison of Survivin Expression by Digital Imaging Analysis and Visual Assessment Among a Cohort of Patients with Clear Cell Renal Cell Carcinoma (2007) (0)
Richter transformation of the ileum presenting with gastrointestinal bleeding. (2013) (0)
Reply by Authors. (2019) (0)
1413 PATIENTS WITH MICROPAPILLARY BLADDER CANCER HAVE COMPARABLE STAGE-ADJUSTED SURVIVAL TO PATIENTS WITH UROTHELIAL CARCINOMA FOLLOWING RADICAL CYSTECTOMY: A MATCHED COHORT ANALYSIS (2012) (0)
924 Comparative performance of comorbidity indices for estimating perioperative and 5-year all-cause mortality following radical cystectomy (2013) (0)
Pathological and oncologic outcomes of “favourable risk” GS 3+4 vs GS 3+3 prostate cancer (2016) (0)
Oncology: Adrenal/Renal/Upper Tract/Bladder Association of Microvascular and Capillary-Lymphatic Invasion with Outcome in Patients with Renal Cell Carcinoma (2013) (0)
Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma and Normal Tissues : Experiences From (Radio) Immunotherapy. Authors' reply (2008) (0)
MP58-02 EVALUATION OF AMERICAN UROLOGICAL ASSOCIATION RENAL CELL CARCINOMA RISK GROUPS FOR CHROMOPHOBE RENAL CELL CARCINOMA (2023) (0)
ASSOCIATION OF PERIOPERATIVE VENOUS THROMBOEMBOLISM WITH LONG‐TERM ONCOLOGIC OUTCOMES FOLLOWING RADICAL CYSTECTOMY: MP10‐11 (2017) (0)
383: Rare Expression or Mutation of C-KIT in Grade 4 Renal Cell Carcinoma with or without Sarcomatoid Differentiation (2006) (0)
386: Tumor B7-H1 is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long Term Follow-Up (2006) (0)
CD-4+ CD-25hi REGULATORY T-CELLS IN THE REGIONAL LYMPH NODES OF PATIENTS WITH UROTHELIAL CARCINOMA (2008) (0)
Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy. (2022) (0)
1756 SIGNET RING VERSUS UROTHELIAL CARCINOMA OF THE BLADDER IN PATIENTS UNDERGOING RADICAL CYSTECTOMY: A MATCHED COHORT ANALYSIS (2013) (0)
MP70-12 IS CONCOMITANT HEPATIC RESECTION FOR LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA AT THE TIME OF NEPHRECTOMY SAFE? A MATCHED COHORT STUDY (2015) (0)
375: Gene Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification of Differential Gene Expression Between Aggressive and Nonaggressive Tumors (2005) (0)
730 ASSOCIATION OF MICROVASCULAR AND CAPILLARY-LYMPHATIC INVASION WITH OUTCOME FOR PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING NEPHRECTOMY (2013) (0)
395 ASSOCIATION OF HER2 STATUS WITH CLINICOPATHOLOGIC OUTCOMES IN MICROPAPILLARY UROTHELIAL CARCINOMA (2013) (0)
1904 THE IMPACT OF NON-CLEAR CELL HISTOLOGY ON OUTCOME FOR PATIENT WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2013) (0)
Comment on: Renal vein or inferior vena caval extension in patients with renal cortical tumors: Impact of tumor histology. Authors' reply (2004) (0)
MP41-20 THE ASSOCIATION OF PREOPERATIVE ASPIRIN USE WITH SURVIVAL FOLLOWING RADICAL CYSTECTOMY (2018) (0)
The probability of indolent versus aggressive histology based on renal tumor size: Implications for surveillance and treatment. (2018) (0)
Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer (2021) (0)
Coffee consumption and risk of renal cell carcinoma (2017) (0)
MP56-20 CLINICOPATHOLOGIC OUTCOMES OF PATIENTS WITH CARCINOMA IN SITU UNDERGOING RADICAL CYSTECTOMY (2014) (0)
Abstract 15: Association of topoisomerase II expression and cancer-specific death in patients with surgically-resected clear cell renal cell carcinoma. (2013) (0)
Creation of a tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. (2018) (0)
Development of Assays for Detecting Significant Prostate Cancer Based on Molecular Alterations Associated with Cancer in Non-Neoplastic Prostate Tissue (2012) (0)
CREATION OF A PREDICTION TOOL FOR RENAL FUNCTION AFTER PARTIAL AND RADICAL NEPHRECTOMY: PERSONALIZING DECISION‐MAKING FOR RENAL CANCER SURGERY: PD66‐07 (2017) (0)
Abstract C43: Prognostic value of hypoxia-associated genes in prostate cancer (2012) (0)
959: Subtype-Specific Multifactorial Postoperative Suriveillance Protocol for Patients with Surgically Treated Renal Cell Carcinoma (2005) (0)
A MOLECULAR SCORING ALGORITHM TO PREDICT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA: PD52‐11 (2017) (0)
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing (2019) (0)
POD-04.07: A gene expression profile predictive of outcome in men at high-risk of systemic progression and death from prostate cancer following radical prostatectomy (2007) (0)
AUA and NCCN surveillance guidelines for RCC: Do they effectively capture recurrences following nephrectomy? (2014) (0)
Serous Borderline Tumor of the Paratestis (2001) (0)
PD57-07 RAPID PATIENT DERIVED XENOGRAFTS THAT CONSIDER TUMOR HETEROGENEITY FOR PREDICTION OF CANCER IMMUNOTHERAPY RESPONSES IN METASTATIC RENAL CELL CARCINOMA (2018) (0)
PREDICTING RENAL CELL CARCINOMA PROGRESSION AFTER SURGERY: MP72‐01 (2017) (0)
MP21-03 CD-70 BLOCKADE AS A NOVEL IMMUNOTHERAPY FOR THE TREATMENT OF CLEAR-CELL RENAL CELL CARCINOMA (2019) (0)
385: PD-1 Expression by Tumor Infiltrating Lymphocytes is Associated with Poor Prognosis in Renal Cell Carcinoma Patients (2006) (0)
Benign and Malignant Epididymal Masses Evaluated With Scrotal (2008) (0)
Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma (2023) (0)
MP34-12 THE ROLE OF SALVAGE LYMPH NODE DISSECTION IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: A SINGLE CENTER EXPERIENCE (2019) (0)
NOVEL DNA METHYLATION MARKERS FOR ACCURATE PROGNOSTIC ASSESSMENT OF PROSTATE CANCER: DISCOVERY AND EARLY VALIDATION: PD71‐03 (2017) (0)
Immune cell marker expressed in kidney cancer and predicts aggressiveness (2004) (0)
Mp70-14 The Oncologic Impact Of Positive Vascular Wall Surgical Margins In Patients With Renal Cell Carcinoma And Venous Tumor Thrombus Undergoing Nephrectomy (2015) (0)
319: Survivin and B7-H1 are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal cell Carcinoma (2007) (0)
PD41-07 EXAMINING THE MD ANDERSON RISK CRITERIA FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: ARE LOW RISK PATIENTS HARMED WITH UPFRONT CYSTECTOMY? (2018) (0)
MP-14.05: A retrospective review of solid epididymal masses evaluated by scrotal sonography with pathologic and clinical correlation (2007) (0)
Abstract 5726: Rearrangement-related peptides with neoantigenic potential in malignant pleural mesothelioma (2018) (0)
Enhanced mRNA FISH with compact quantum dots (2018) (0)
Abstract 116: Targeting hypoxia for the identification of novel biomarkers for prostate cancer (2012) (0)
390 THE IMPACT OF MIXED HISTOLOGAL FEATURES ON SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA (2012) (0)
MP64-08 CONTEMPORARY UTILIZATION OF THE SSIGN SCORE (2016) (0)
Bim Expression in Peritumoral Lymphocytes is Associated with Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma (2021) (0)
PD57-02 CREATION OF A TISSUE EXPRESSION BIOMARKER-AUGMENTED PROGNOSTIC MODEL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2018) (0)
PD10-11 AUA AND NCCN SURVEILLANCE GUIDELINES FOR RCC: DO THEY EFFECTIVELY CAPTURE RECURRENCES FOLLOWING NEPHRECTOMY? (2014) (0)
Theragnostic chromosomal rearrangements in treatment‐naive pancreatic ductal adenocarcinomas obtained via endoscopic ultrasound (2021) (0)
387: The Immunomodulatory Protein B7-H4 Expression in Renal Cell Carcinoma Patients: A Strong Predictor of Cancer Progression and Survival (2006) (0)
Abstract B42: Overexpression of ENRAGE is an obesity-related alteration in clear cell renal cell carcinoma (2013) (0)
1902 PROGNOSTIC SIGNIFICANCE OF MEASURED DEPTH OF INVASION OF BLADDER UROTHELIAL CARCINOMA VERSUS 2010 AMERICAN JOINT COMMITTEE ON CANCER (AJCC) PT CLASSIFICATION (2012) (0)
1984 ONCOLOGIC FOLLOW-UP AFTER RADICAL CYSTECTOMY TO DETECT ASYMPTOMATIC RECURRENCE IS ASSOCIATED WITH IMPROVED PATIENT SURVIVAL (2011) (0)
Defining permanent prostate brachytherapy target volumes from evaluation of whole-mount prostatectomy specimens (2005) (0)
Diabetes mellitus and risk of cancer-specific mortality among patients with clear cell renal cell carcinoma undergoing nephrectomy. (2014) (0)
MP32-15 CIGARETTE SMOKING IS ASSOCIATED WITH ADVERSE PATHOLOGIC RESPONSE AND INCREASED DISEASE RECURRENCE AMONG PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER TREATED WITH CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY (2019) (0)
87: Dynamic Outcome Prediction in Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy (2006) (0)
Bladder Cancer: Invasive VMP72-11 OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR PLASMACYTOID UROTHELIAL CARCINOMA: DEFINING THE NEED FOR IMPROVED LOCAL CANCER CONTROL (2015) (0)
LONG-TERM OUTCOME OF MULTIPLE IPSILATERAL RENAL TUMORS FOUND AT TIME OF PLANNED NEPHRON SPARING SURGERY (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John C. Cheville?

John C. Cheville is affiliated with the following schools:

Nanjing Normal University
University of Tsukuba
Mayo Clinic College of Medicine and Science
Duke University
University of Texas Southwestern Medical Center

John C. Cheville's Academic­Influence.com Rankings

Why Is John C. Cheville Influential?

John C. Cheville's Published Works

Published Works

What Schools Are Affiliated With John C. Cheville?

John C. Cheville's AcademicInfluence.com Rankings